Study of Ebola vaccine booster in previously vaccinated adults
Part of Infections clinical trials.
This study tests if a booster dose of one of two Ebola vaccines (Ervebo® or Zabdeno®) is safe and works well in people who already got an Ebola vaccine more than 4 months ago. It's especially for people living in the Democratic Republic of Congo (DRC) who may have been vaccinated before and might need a stronger, longer-lasting immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 50 years old
- You received either the Ervebo® or the full Zabdeno/Mvabea® Ebola vaccine more than 4 months ago
- You have never had Ebola virus disease
- You haven't received any other vaccine or an extra Ebola booster in the last 30 days
- You do not have a weakened immune system, a bleeding disorder, or a history of blood clots
- You are willing to share your medical history and avoid blood donation or other vaccines for 30 days after the booster
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether giving an Ebola treatment (Inmazeb) before the Ebola vaccine (Ervebo) changes the vaccine's effect on healthy people. It helps understand the best timing for these treatments.
This trial tests a new medicine to prevent Ebola after you have been exposed. If you had close contact with someone who has Ebola in the last 5 days, this study could help you stay healthy.
This trial provides an experimental antibody treatment called REGN-EB3 to people infected with Ebola virus. It aims to treat the infection and potentially improve recovery, and is available through special access in areas with Ebola outbreaks.
This trial provides an experimental antibody treatment called ansuvimab to people who have Ebola or have been recently exposed to it. The goal is to help their bodies fight the virus and prevent illness.
This study tests a new Ebola vaccine to see if it is safe and how well it works. Healthy volunteers receive the vaccine and are monitored for side effects and immune response.
This study tests whether a single booster dose of the rabies vaccine is still effective in people who received the primary pre-exposure series several years ago. It compares three different vaccine regimens to see which one boosts immunity best.
Hear when a new Ebola Virus Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.